Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

COPIKTRA (duvelisib) Indicated for chronic lymphocytic leukaemia

Drug Name

COPIKTRA (duvelisib)

Developers

Verastem

Therapy Class

Kinase inhibitor

Product Description

Dual PI3K-δ and PI3K-γ inhibitor

Current Indication

Chronic lymphocytic leukaemia, small lymphocytic lymphoma and follicular lymphoma

Market Sector

Oncology

Development Status

Approved in the US
Expand

Go Top